Table 5.

Supplementation with 30 mg/kg BW/day XN or its derivatives DXN and TXN alters the fecal bile acid profile

Bile Acid Group	CON	XN	DXN	TXN	SEM	XN vs CON	DXN vs CON	TXN vs CON
Bile Acid	Peak Intensity (LS mean)					P-values (Comparisons)
Total	18,866	15,352	29,309	29,618	3,200	0.40	0.02	0.02
Unconjugated Primary	1,555	1,384	997	864	198	0.51	0.04	0.01
CA	450	383	414	257	109	0.64	0.80	0.20
αMCA	107	92	43	35	9	0.24	<0.001	<0.001
βMCA	998	909	539	572	118	0.56	0.004	0.01
Conjugated Primary	13,920	10,660	25,868	26,350	2,828	0.36	0.008	0.01
TCA	1,378	1,069	5,851	6,202	908	0.79	<0.001	<0.001
TCDCA	358	857	399	205	150	0.01	0.83	0.46
TαMCA	748	621	1,009	1,471	154	0.53	0.20	0.001
TβMCA	11,435	8,113	18,608	18,471	1,988	0.20	0.08	0.01
Unconj. Dehydroxylated	1,420	1,289	427	314	147	0.50	<0.001	<0.001
DCA	1,160	1,047	385	282	126	0.49	<0.001	<0.001
UDCA	22	12	4	3	3	0.009	<0.001	<0.001
HDCA	238	229	38	29	23	0.77	<0.001	<0.001
Conjug. Dehydroxylated	1,972	2,019	2,017	2,090	408	0.93	0.93	0.83
TDCA	179	224	264	325	66	0.60	0.33	0.11
TUDCA	939	678	742	507	288	0.49	0.60	0.27
TωMCA	854	1,116	1,011	1,258	228	0.38	0.60	0.20
Ratios
CA/DCA	0.36	0.40	1.78	2.83	0.50	0.95	0.05	0.002
CA/TCA	0.46	0.47	0.12	0.09	0.08	0.87	0.002	0.001
αMCA/TαMCA	0.208	0.180	0.048	0.023	0.036	0.56	0.001	0.0005
βMCA/TβMCA	0.102	0.133	0.032	0.032	0.013	0.07	0.0001	0.0002
Conjugated/Unconj.	5.02	5.06	28.2	48.2	7.1	0.99	0.02	<0.0001